Kahn Brothers' Strategic Moves: GSK PLC Sees a -3.08% Impact

This article first appeared on GuruFocus.

Exploring Kahn Brothers (Trades, Portfolio)' Recent 13F Filing and Investment Strategies

Warning! GuruFocus has detected 3 Warning Sign with BOM:533217. Is C fairly valued? Test your thesis with our free DCF calculator.

Kahn Brothers (Trades, Portfolio) recently submitted their 13F filing for the third quarter of 2025, offering a glimpse into their strategic investment decisions during this period. Founded in 1978 by Irving Kahn, Thomas Graham Kahn, and Alan Kahn, Kahn Brothers (Trades, Portfolio) Group is a distinguished investment firm catering to institutional and high-net-worth clients. The firm operates through Kahn Brothers (Trades, Portfolio) Advisors LLC for investment management and Kahn Brothers (Trades, Portfolio) LLC for brokerage services. With a legacy rooted in value investing, the firm employs a bottom-up stock selection approach, focusing on undervalued equities that are often overlooked by the market. This strategy is deeply influenced by Benjamin Graham's investment philosophies, a testament to Irving Kahn's early career as Graham's teaching assistant at Columbia Business School.Kahn Brothers' Strategic Moves: GSK PLC Sees a -3.08% Impact

Summary of New Buy

Kahn Brothers (Trades, Portfolio) added a total of five stocks to their portfolio this quarter. The most significant addition was Seaport Entertainment Group Inc (NYSE:SEG), with 583,364 shares, accounting for 2.51% of the portfolio and valued at $13.37 million. The second largest addition was MBIA Inc (NYSE:MBI), consisting of 1,029,794 shares, representing approximately 1.44% of the portfolio, with a total value of $7.67 million. The third largest addition was American Express Co (NYSE:AXP), with 1,150 shares, accounting for 0.07% of the portfolio and valued at $381,980.

Key Position Increases

Kahn Brothers (Trades, Portfolio) also increased their stakes in five stocks. The most notable increase was in Alphabet Inc (NASDAQ:GOOG), with an additional 63,631 shares, bringing the total to 134,722 shares. This adjustment represents a significant 89.51% increase in share count, impacting the portfolio by 2.91%, with a total value of $32.81 million. The second largest increase was in Organon & Co (NYSE:OGN), with an additional 126,695 shares, bringing the total to 3,616,845. This adjustment represents a 3.63% increase in share count, with a total value of $38.63 million.

Summary of Sold Out

Kahn Brothers (Trades, Portfolio) completely exited two holdings in the third quarter of 2025. They sold all 2,349 shares of American International Group Inc (NYSE:AIG), resulting in a -0.04% impact on the portfolio. Additionally, they liquidated all 166,999 shares of Trinity Place Holdings Inc (TPHS), causing a -0% impact on the portfolio.

Story Continues

Key Position Reduces

Kahn Brothers (Trades, Portfolio) reduced their position in 27 stocks, with the most significant changes including a reduction in GSK PLC (NYSE:GSK) by 399,035 shares, resulting in a -60.47% decrease in shares and a -3.08% impact on the portfolio. The stock traded at an average price of $39.06 during the quarter and has returned 27.39% over the past three months and 47.27% year-to-date. They also reduced Bristol-Myers Squibb Co (NYSE:BMY) by 278,349 shares, resulting in a -50.55% reduction in shares and a -2.59% impact on the portfolio. The stock traded at an average price of $46.70 during the quarter and has returned 7.76% over the past three months and -8.17% year-to-date.

Portfolio Overview

As of the third quarter of 2025, Kahn Brothers (Trades, Portfolio)' portfolio included 53 stocks. The top holdings were 16.73% in Citigroup Inc (NYSE:C), 10.58% in Bayer AG (BAYRY), 9.33% in Flagstar Bank NA (NYSE:FLG), 8.49% in The Walt Disney Co (NYSE:DIS), and 7.26% in Organon & Co (NYSE:OGN).

The holdings are primarily concentrated in nine of the eleven industries: Healthcare, Financial Services, Communication Services, Energy, Industrials, Real Estate, Utilities, Technology, and Consumer Defensive.

View Comments